A synthetic CDN (ML RR-S2 CDA), which activates both mSTING and hSTING, induces lasting immune-mediated antitumor activity in various models including B16-F10 melanoma cell-triggered lung metastases [54]. This evidence concerns the gene STING1 and melanoma.